Jeffrey Wu
Showing 1–2 of 2 transcripts.
- a16z20 min
a16z Podcast | The Future of... You
Daniel Chao, Rob Rhinehart, James Rogers, Geoffrey Woo, Chris Dixon, Hannah, Jeffrey Wu, Rob Reifart
At the inaugural A16Z summit, CEOs from Halo Neuroscience, Nutribox, Soylent, and Appeal discussed how material science, direct-to-consumer models, and sensor technology are converging to optimize human cognition and physical performance. The panel highlighted specific innovations ranging from Halo's motor cortex neurostimulation for accelerated skill acquisition to Appeal's molecular barriers that triple produce shelf life, alongside Soylent's vision for single-celled organism agriculture. By treating the human body as an engineering system and leveraging e-commerce to bypass traditional retail risks, these companies aim to integrate enhancement directly into daily food and health routines rather than relying on niche pharmaceuticals.
- a16z23 min
a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself
Geoffrey Woo, Michael Brandt, Kyle Russell, Jeffrey Wu, Sakantala Pansaratne
Founders of NutriBox are positioning their company as a clinical bridge between amateur biohacking and mainstream cognitive enhancement by deploying MD-PhD teams to verify nootropic formulations through double-blind trials. This venture challenges the supplement industry's opaque "proprietary blend" model with open-source ingredient ratios and is expanding beyond standard pills into novel formats like "Go Cubes" and personalized data-driven stacks. The founders predict this rigorous approach will catalyze a new wave of billion-dollar human enhancement firms that democratize access to optimal cognitive baselines without relying on traditional pharmaceutical patents.